Assignee
WYVERN PHARMACEUTICALS INC
CA·93 granted patents·5 pending applications·377 citations·filing 2019–2025
Top patents by PatentIndex Score
98 records- 0199US12195747B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2023·Granted Jan 14, 2025·39 cites·8 claims
- 0299US12134770B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Nov 5, 2024·87 cites·15 claims
- 0399US12018274B2Compositions and methods for regulating production of a fusion protein and ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·79 cites·4 claims
- 0499US11873505B2Compositions and methods for regulating production of a precursor proteinWYVERN PHARMACEUTICALS INC·Filed 2020·Granted Jan 16, 2024·81 cites·3 claims
- 0599US11530423B1Composition for regulating production of ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2022·Granted Dec 20, 2022·83 cites·16 claims
- 0698US12281306B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Apr 22, 2025·7 cites·6 claims
- 0796US12540327B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·4 claims
- 0896US12540326B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·2 claims
- 0995US12595484B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Apr 7, 2026·0 cites·4 claims
- 1095US12570979B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Mar 10, 2026·0 cites·4 claims
- 1195US12565657B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Mar 3, 2026·0 cites·4 claims
- 1295US12559751B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 24, 2026·0 cites·4 claims
- 1395US12559756B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 24, 2026·0 cites·4 claims
- 1495US12540322B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·4 claims
- 1595US12540328B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·2 claims
- 1695US12540329B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·2 claims
- 1795US12534733B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 27, 2026·0 cites·4 claims
- 1895US12522833B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·4 claims
- 1995US12522828B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·4 claims
- 2095US12522829B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·4 claims
- 2195US12522832B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·4 claims
- 2295US12516327B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 6, 2026·0 cites·3 claims
- 2395US12516325B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 6, 2026·0 cites·3 claims
- 2495US12516324B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 6, 2026·0 cites·4 claims
- 2595US12509686B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·3 claims
- 2695US12509693B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·4 claims
- 2795US12509692B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·3 claims
- 2895US12497620B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 16, 2025·0 cites·3 claims
- 2995US12497619B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 16, 2025·0 cites·2 claims
- 3095US12486508B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·2 claims
- 3195US12486507B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·2 claims
- 3294US12584134B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Mar 24, 2026·0 cites·3 claims
- 3394US12509690B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·4 claims
- 3494US12509691B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·3 claims
- 3594US12509689B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·4 claims
- 3694US12486511B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·3 claims
- 3794US12486510B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·3 claims
- 3894US12486509B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·3 claims
- 3994US12162927B1Compositions and methods for regulating production of an antibody like protein and ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·1 cites·11 claims
- 4093US12522831B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·3 claims
- 4192US12559754B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2023·Granted Feb 24, 2026·0 cites·2 claims
- 4292US12540324B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·3 claims
- 4392US12529075B2Plasmid encoding a NGF and Fc fusion proteinWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 20, 2026·0 cites·3 claims
- 4492US12522847B2Plasmid encoding an insulin peptide and Fc fusion proteinWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·3 claims
- 4592US12497633B2Plasmid encoding a TLR9 and Fc fusion proteinWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Dec 16, 2025·0 cites·3 claims
- 4692US12421528B2Plasmid encoding a DNAse-I and Fc fusion proteinWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Sep 23, 2025·0 cites·3 claims
- 4792US2025340889A1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4891US12460209B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Nov 4, 2025·0 cites·2 claims
- 4990US12473555B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Nov 18, 2025·0 cites·2 claims
- 5090US12460210B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Nov 4, 2025·0 cites·2 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when WYVERN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →